Your browser doesn't support javascript.
loading
A polygenic risk score analysis of psychosis endophenotypes across brain functional, structural, and cognitive domains.
Ranlund, Siri; Calafato, Stella; Thygesen, Johan H; Lin, Kuang; Cahn, Wiepke; Crespo-Facorro, Benedicto; de Zwarte, Sonja M C; Díez, Álvaro; Di Forti, Marta; Iyegbe, Conrad; Jablensky, Assen; Jones, Rebecca; Hall, Mei-Hua; Kahn, Rene; Kalaydjieva, Luba; Kravariti, Eugenia; McDonald, Colm; McIntosh, Andrew M; McQuillin, Andrew; Picchioni, Marco; Prata, Diana P; Rujescu, Dan; Schulze, Katja; Shaikh, Madiha; Toulopoulou, Timothea; van Haren, Neeltje; van Os, Jim; Vassos, Evangelos; Walshe, Muriel; Lewis, Cathryn; Murray, Robin M; Powell, John; Bramon, Elvira.
Afiliação
  • Ranlund S; Division of Psychiatry, University College London, London, UK.
  • Calafato S; Institute of Psychiatry Psychology and Neuroscience at King's College London and South London, Maudsley NHS Foundation Trust, London, UK.
  • Thygesen JH; Division of Psychiatry, University College London, London, UK.
  • Lin K; Division of Psychiatry, University College London, London, UK.
  • Cahn W; Institute of Psychiatry Psychology and Neuroscience at King's College London and South London, Maudsley NHS Foundation Trust, London, UK.
  • Crespo-Facorro B; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • de Zwarte SMC; Department of Psychiatry, Brain Centre Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Díez Á; CIBERSAM, Centro Investigación Biomédica en Red Salud Mental, Madrid, Spain.
  • Di Forti M; Department of Psychiatry, University Hospital Marqués de Valdecilla, School of Medicine, University of Cantabria-IDIVAL, Santander, Spain.
  • Iyegbe C; Division of Psychiatry, University College London, London, UK.
  • Jablensky A; Laboratory of Cognitive and Computational Neuroscience-Centre for Biomedical Technology (CTB), Complutense University and Technical University of Madrid, Madrid, Spain.
  • Jones R; Institute of Psychiatry Psychology and Neuroscience at King's College London and South London, Maudsley NHS Foundation Trust, London, UK.
  • Kahn R; Institute of Psychiatry Psychology and Neuroscience at King's College London and South London, Maudsley NHS Foundation Trust, London, UK.
  • Kalaydjieva L; Centre for Clinical Research in Neuropsychiatry, The University of Western Australia, Perth, Western Australia, Australia.
  • Kravariti E; Division of Psychiatry, University College London, London, UK.
  • McDonald C; Psychosis Neurobiology Laboratory, Harvard Medical School, McLean Hospital, Belmont, Massachusetts.
  • McIntosh AM; Department of Psychiatry, Brain Centre Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.
  • McQuillin A; Harry Perkins Institute of Medical Research and Centre for Medical Research, The University of Western Australia, Perth, Australia.
  • Picchioni M; The Centre for Neuroimaging & Cognitive Genomics (NICOG) and NCBES Galway Neuroscience Centre, National University of Ireland Galway, Galway, Ireland.
  • Prata DP; Division of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK.
  • Rujescu D; Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK.
  • Schulze K; Division of Psychiatry, University College London, London, UK.
  • Toulopoulou T; Institute of Psychiatry Psychology and Neuroscience at King's College London and South London, Maudsley NHS Foundation Trust, London, UK.
  • van Haren N; Institute of Psychiatry Psychology and Neuroscience at King's College London and South London, Maudsley NHS Foundation Trust, London, UK.
  • van Os J; Faculdade de Medicina, Instituto de Medicina Molecular, Universidade de Lisboa, Portugal.
  • Vassos E; Department of Psychiatry, Ludwig-Maximilians University of Munich, Munich, Germany.
  • Walshe M; Department of Psychiatry, Psychotherapy and Psychosomatics, University of Halle Wittenberg, Halle, Germany.
  • Lewis C; North East London Foundation Trust, London, UK.
  • Murray RM; Research Department of Clinical, Educational and Health Psychology, University College London, London, UK.
  • Powell J; Institute of Psychiatry Psychology and Neuroscience at King's College London and South London, Maudsley NHS Foundation Trust, London, UK.
  • Bramon E; Department of Psychology, Bilkent University, Main Campus, Bilkent, Ankara, Turkey.
Am J Med Genet B Neuropsychiatr Genet ; 177(1): 21-34, 2018 Jan.
Article em En | MEDLINE | ID: mdl-28851104
ABSTRACT
This large multi-center study investigates the relationships between genetic risk for schizophrenia and bipolar disorder, and multi-modal endophenotypes for psychosis. The sample included 4,242 individuals; 1,087 patients with psychosis, 822 unaffected first-degree relatives of patients, and 2,333 controls. Endophenotypes included the P300 event-related potential (N = 515), lateral ventricular volume (N = 798), and the cognitive measures block design (N = 3,089), digit span (N = 1,437), and the Ray Auditory Verbal Learning Task (N = 2,406). Data were collected across 11 sites in Europe and Australia; all genotyping and genetic analyses were done at the same laboratory in the United Kingdom. We calculated polygenic risk scores for schizophrenia and bipolar disorder separately, and used linear regression to test whether polygenic scores influenced the endophenotypes. Results showed that higher polygenic scores for schizophrenia were associated with poorer performance on the block design task and explained 0.2% (p = 0.009) of the variance. Associations in the same direction were found for bipolar disorder scores, but this was not statistically significant at the 1% level (p = 0.02). The schizophrenia score explained 0.4% of variance in lateral ventricular volumes, the largest across all phenotypes examined, although this was not significant (p = 0.063). None of the remaining associations reached significance after correction for multiple testing (with alpha at 1%). These results indicate that common genetic variants associated with schizophrenia predict performance in spatial visualization, providing additional evidence that this measure is an endophenotype for the disorder with shared genetic risk variants. The use of endophenotypes such as this will help to characterize the effects of common genetic variation in psychosis.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Transtorno Bipolar Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Europa / Oceania Idioma: En Revista: Am J Med Genet B Neuropsychiatr Genet Assunto da revista: GENETICA MEDICA / NEUROLOGIA / PSIQUIATRIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Transtorno Bipolar Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Europa / Oceania Idioma: En Revista: Am J Med Genet B Neuropsychiatr Genet Assunto da revista: GENETICA MEDICA / NEUROLOGIA / PSIQUIATRIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido